Table 1 Demographic and clinical variables among concurrent infections cases
From: Concurrent infections of dengue virus serotypes in Bali, Indonesia
Variable | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 | Case 7 | Case 8 |
|---|---|---|---|---|---|---|---|---|
Demography and clinical manifestations | ||||||||
Age range, years old | 20–30 | 20–30 | 30–40 | 40–50 | 30–40 | 40–50 | 50–60 | 50–60 |
Race/nationality | Balinese | Balinese | Balinese | Balinese | Balinese | French | French | Austrian |
Gender | Male | Female | Male | Male | Male | Female | Male | Male |
Fever day | 3 | 3 | 3 | 5 | 2 | 3 | 3 | 3 |
Headache | + | + | + | – | – | + | + | + |
Arthralgia | + | + | + | + | – | + | – | + |
Myalgia | + | + | + | + | – | + | – | + |
Vomiting | + | + | – | – | – | + | – | – |
Bleeding manifestation | + (Petechiae) | – | – | – | – | + (Gum) | – | – |
Shock | – | – | – | – | – | – | – | – |
Plasma leakage | – | + | – | + | – | – | – | – |
Comorbidity | – | – | – | – | – | – | + (DVT) | – |
Laboratory examinations data | ||||||||
Nadir WBC (× 10 µg/µL) | 4.10 | 3.00 | 2.70 | 2.90 | 2.06 | 1.16 | 2.84 | 1.13 |
HCT difference (%) | 12.0 | 21.4 | 9.9 | 21 | 11.9 | 6.1 | 7.4 | 11.1 |
Nadir PLT (× 109/L) | 122 | 91 | 16 | 56 | 114 | 56 | 117 | 113 |
AST (U/L) | 34 | 167 | N/A | 164 | N/A | 24 | 59 | 40 |
ALT (U/L) | 23 | 190 | N/A | 168 | N/A | 14 | 42 | 36 |
Albumin (g/L) | 3.8 | 3.0 | N/A | 3.4 | N/A | N/A | 3.8 | 3.8 |
DENV NS1 | + | + | + | + | + | + | + | + |
Dengue IgM | + | + | – | + | + | + | + | + |
Dengue IgG | + | + | + | + | + | – | – | – |
Infection status | Secondary | Secondary | Secondary | Secondary | Secondary | Primary | Primary | Primary |
Severity | DF | DHF grade 1 | DF | DHF grade 1 | DF | DF | DF | DF |
DENV Serotype (RT-PCR Ct value)a | DENV-2 (19.8), DENV-4 (38.7) | DENV-1 (16.0), DENV-2 (35.1) | DENV-1 (16.3), DENV-3 (29.2) | DENV-1 (33.3), DENV-3 (31.9) | DENV-3 (29.0), DENV-4 (38.5) | DENV-1 (29.1), DENV-2 (29.1) | DENV-1 (25.2), DENV-2 (20.6) | DENV-2 (24.5), DENV-4 (22.7) |